Chicken Pox in Humans: Etiology, Clinical Features, and Differential Diagnosis from Avian Diseases

Introduction

The term "chicken pox" is a source of considerable nosological confusion in veterinary and comparative medicine. In human medicine, chicken pox refers to varicella, a highly contagious exanthematous disease caused by the varicella-zoster virus (VZV), a member of the Alphaherpesvirinae subfamily [1, 2]. In avian medicine, the term "chicken pox" is commonly (though imprecisely) used to describe fowl pox, a disease caused by a completely unrelated virus, Avipoxvirus, a member of the Chordopoxvirinae subfamily. This article provides a rigorous, publication-grade reference for veterinary diagnosticians, clarifying the etiology of human varicella, detailing its clinical features, and establishing a systematic differential diagnosis from avian poxvirus infections and other poultry diseases. Understanding the biological distinction between "chicken pox bacteria or virus" is critical; the causative agent of human varicella is definitively a virus, not a bacterium, and the question of a "chicken pox bacteria name" is a misnomer, as no bacterial pathogen causes this specific human syndrome [3, 4]. Furthermore, the concept of "chicken parasites in humans" is addressed to differentiate VZV from zoonotic agents that may cause dermatological signs in poultry workers.

Etiology of Human Chicken Pox (Varicella)

The Pathogen: Varicella-Zoster Virus

Varicella-zoster virus is a highly species-specific human alphaherpesvirus [5, 2]. Humans are the only known natural reservoir and host for VZV [1, 6]. The virus is not a bacterium; it is a linear, double-stranded DNA virus with an icosahedral capsid and a lipid envelope [6]. The genome is approximately 125 kb in length and encodes over 70 open reading frames (ORFs) [7, 8]. Key glycoproteins involved in viral entry and cell-to-cell spread include glycoprotein E (gE), gB, gH, and gL [9, 10, 11]. The gE protein, in particular, is a major immunogen and the target of subunit vaccines [10, 12].

Virological and Biophysical Properties

Varicella-zoster virus is relatively labile in the environment. Its lipid envelope is susceptible to desiccation, detergents, and disinfectants [2]. Unlike avian poxviruses, which are environmentally robust, VZV requires close contact for efficient transmission [1]. The virus exhibits a tropism for T lymphocytes, epithelial cells, and neurons [5, 2, 13]. Following primary infection, VZV establishes lifelong latency in the sensory ganglia of the cranial nerve and dorsal root ganglia [13, 14, 8]. Reactivation of the latent virus leads to herpes zoster (shingles), a condition characterized by a unilateral, dermatomal rash [15, 16, 13]. The molecular mechanisms governing latency and reactivation involve highly restricted viral gene transcription and epigenetic regulation [13, 8]. A novel latency-associated transcript (VLT) has been identified, mapping antisense to the viral transactivator gene 61 [13, 8]. In vitro models using human stem cell-derived neurons have identified the c-Jun N-terminal kinase (JNK) and phosphoinositide 3-kinase (PI3K) pathways as potential modulators of VZV latency [14].

Transmission and Epidemiology

Primary VZV infection occurs predominantly in childhood [1, 17]. The virus is transmitted via the respiratory route through aerosolized droplets or through direct contact with vesicular fluid from skin lesions [1, 2]. The incubation period typically ranges from 10 to 21 days [1]. Outbreaks are common in congregate settings, and the disease is characterized by high attack rates among susceptible individuals [1, 18]. VZV is distributed globally, and while infection is generally self-limiting, it can cause significant morbidity and mortality in immunocompromised individuals, neonates, and pregnant women [19, 20, 17].

Clinical Features of Human Varicella

Prodromal Phase and Cutaneous Manifestations

The clinical hallmark of varicella is a generalized, pruritic, vesicular rash [1, 2]. The prodromal phase, which may precede the rash by 1 to 2 days, often includes fever, malaise, headache, and anorexia [1]. The rash typically begins on the scalp, face, and trunk before spreading to the extremities [2]. The lesions evolve rapidly through stages: macule, papule, vesicle (the classic "dew drop on a rose petal" appearance), pustule, and finally crust [2, 6]. Lesions appear in successive crops, resulting in the simultaneous presence of lesions at different stages of development in the same anatomical region [2].

Atypical Presentations and Complications

While usually benign in immunocompetent children, varicella can present atypically. Bullous varicella is a rare but recognized form characterized by the development of large blisters, particularly in immunocompromised children [17]. A "gloves and socks" syndrome variant has also been described [21]. Complications include secondary bacterial superinfection of skin lesions, pneumonitis, encephalitis, cerebellar ataxia, and thrombocytopenia [1, 16]. In adults and immunocompromised individuals, the disease is often more severe, with a higher risk of visceral dissemination [19, 17]. Reactivation of VZV as herpes zoster can lead to postherpetic neuralgia (PHN), a debilitating chronic pain syndrome, as well as vasculopathy, myelitis, and cranial nerve syndromes [15, 16, 22, 23]. VZV vasculopathy can result in ischemic stroke and has been controversially linked to giant cell arteritis (GCA) [16, 22].

Differential Diagnosis from Avian Diseases

The term "chicken pox" in the context of poultry leads to the most critical differential diagnosis for the veterinary professional. The primary differential is infection with avian poxvirus, but other diseases with cutaneous or vesicular-like lesions must be considered.

Avian Poxvirus Infection (Fowl Pox)

Avian pox is caused by viruses of the genus Avipoxvirus (family Poxviridae). This is a completely different virus from VZV. The disease is characterized by proliferative, wart-like lesions on the unfeathered skin (cutaneous form) or diphtheritic lesions in the upper respiratory and digestive tracts (diphtheritic form) [see article on Avian Poxvirus]. Unlike the vesicular lesions of human varicella, avian pox lesions are typically dry, crusty, and hyperplastic. The virions of poxviruses are large, brick-shaped, and environmentally stable, in stark contrast to the labile, enveloped VZV. Transmission is via mosquito vectors or direct contact. The molecular pathogenesis involves viral replication in the cytoplasm, a feature unique to poxviruses, whereas herpesviruses replicate in the nucleus.

Other Vesicular and Papular Diseases in Poultry

1. Infectious Laryngotracheitis (ILT): Caused by Gallid alphaherpesvirus 1, ILT primarily presents with severe respiratory distress, conjunctivitis, and hemorrhagic tracheitis. It does not produce generalized skin vesicles but can cause conjunctival edema and hemorrhage.
2. Marek's Disease (MD): Caused by Gallid alphaherpesvirus 2, MD is a lymphoproliferative disease. While it can cause skin lesions (skin leukosis), these are typically tumorous, raised, and non-vesicular.
3. Infectious Coryza: Caused by the bacterium Avibacterium paragallinarum, this disease presents with facial edema, nasal discharge, and conjunctivitis, but does not cause vesicular skin lesions [see articles on Infectious Coryza].
4. Fowl Cholera: Caused by Pasteurella multocida, this bacterial septicemia can cause cyanosis and petechiation of the skin but not true vesicles [see articles on Fowl Cholera].
5. Bumblefoot and Scaly Leg Mite: These conditions cause proliferative or crusting lesions on the feet and legs. Knemidocoptes mutans (scaly leg mite) burrows under scales, causing a thick, crusty appearance that can mimic pox lesions on the legs [see articles on Scaly Leg Mite].

"Chicken Parasites in Humans" and Differential Diagnosis

Veterinary professionals must be able to differentiate VZV lesions from zoonotic agents that poultry workers may encounter. While VZV is not a poultry infection, lesions in a person with poultry exposure could be mistaken for:

• Orf (Contagious Ecthyma): Caused by a Parapoxvirus primarily from sheep and goats, but can be transmitted to humans via fomites.
• Dermatophytosis (Ringworm): Fungal infections from poultry (e.g., Microsporum gallinae) can cause circular, scaly, pruritic lesions.
• Mite Bites (e.g., Dermanyssus gallinae): The poultry red mite can cause a papular, pruritic dermatitis in humans.
• Avian Tuberculosis: Caused by Mycobacterium avium subsp. avium, this can cause granulomatous skin lesions in immunocompromised humans, but not acute vesicular rashes [see article on Mycobacterium avium].

The key differentiating factor is the clinical history (e.g., exposure to chickens vs. exposure to a child with varicella), the nature of the lesions (vesicular, "dewdrop" vs. dry, crusty), and laboratory testing.

Diagnostic Approaches

Laboratory Confirmation of VZV

For clinical and epidemiological confirmation, several laboratory methods are employed. Polymerase chain reaction (PCR) is the gold standard for detecting VZV DNA from vesicular fluid, crusts, or cerebrospinal fluid [17, 2]. Direct fluorescent antibody (DFA) testing on smears from vesicle bases is a rapid alternative. Serological testing for VZV-specific IgM (indicating recent primary infection) or IgG (indicating past infection or vaccination) is widely used [12]. Complement fixation tests have historical significance [24]. Viral culture is possible but slow and less sensitive [2].

Differentiation from Avian Pox

Diagnostic differentiation from avian pox relies on:

• Histopathology: Avian pox lesions show characteristic Bollinger bodies (intracytoplasmic eosinophilic inclusion bodies) in epithelial cells. VZV lesions show multinucleated giant cells (Tzanck cells) and intranuclear inclusions (Cowdry type A).
• Electron Microscopy: Avian pox virions are brick-shaped (approximately 300 x 250 nm), whereas VZV virions are spherical with an icosahedral capsid (approximately 180 nm).
• Molecular Testing: PCR assays specific for Avipoxvirus DNA or VZV DNA provide definitive differentiation.

Diagnostic Workflow

A decision tree for differential diagnosis when a patient (human or avian) presents with a pox-like condition is provided below.

graph TD
    A[Patient presents with pox-like lesions], > B{What is the patient species?};
    B, >|Human| C[History: Exposure to humans with rash?];
    C, > D[Lesions: Vesicular, 'dew drop', different stages];
    D, > E[Laboratory: PCR for VZV DNA, Tzanck smear];
    E, > F[Confirmed Varicella-Zoster];
    
    B, >|Avian (Chicken)| G[History: Mosquito exposure? New bird?];
    G, > H[Lesions: Dry, crusty, wart-like on unfeathered skin];
    H, > I[Laboratory: PCR for Avipoxvirus, histology for Bollinger bodies];
    I, > J[Confirmed Avian Pox (Fowl Pox)];

    A, > K{Other differentials};
    K, >|Human with poultry exposure| L[Consider: Orf, Dermatophytosis, Mite bites, Avian TB];
    K, >|Avian| M[Consider: Marek's Disease, ILT, Bumblefoot, Scaly Leg Mite];

    style F fill:#f9f,stroke:#333,stroke-width:2px
    style J fill:#bbf,stroke:#333,stroke-width:2px

Public Health and Veterinary Interface

A One Health approach is essential for managing diseases at the human-animal interface. While human VZV is not a zoonotic disease, its name creates confusion in agricultural settings. It is important for veterinarians and poultry producers to distinguish between human varicella and avian pox to implement appropriate biosecurity and public health measures. Human varicella outbreaks in rural communities, such as those in internally displaced populations, highlight the need for robust surveillance and vaccination [1]. Although VZV is human-specific, the principles of controlling a highly infectious, airborne pathogen are transferable to managing outbreaks of avian herpesviruses like ILT. The role of vaccination in controlling VZV is well established, and live-attenuated vaccines are used in many national immunization programs [12]. Conversely, avian pox can be controlled through vaccination in endemic areas and through vector management.

References

[1] Tilahun, H., Alayu, M., Demssie, M., et al. Suspected Chicken Pox Outbreak Investigation and Response in Yirga Chefe Town, Ethiopia, August 2018. Journal. (2020). URL: https://www.semanticscholar.org/paper/4ced07431d9cdd0ad513423fbe0c90370e29f52f

[2] Arvin, A. Creating the "Dew Drop on a Rose Petal": the Molecular Pathogenesis of Varicella-Zoster Virus Skin Lesions. Microbiology and Molecular Biology Reviews. (2023). URL: https://www.semanticscholar.org/paper/906184c7214533677dfe552a1263013bbff9df26

[3] Thomson, R., Brownlee, J. PRELIMINARY NOTE ON THE PARASITES OF SMALL-POX AND CHICKEN-POX. British medical journal. (1903). URL: https://www.semanticscholar.org/paper/a92fe4942823cfdc3ae45ce398bdd04f1c2ff963

[4] Sprunt, K., Hirst, G. K. Isolation of a New Infectious Agent from the Vesicles of Chicken Pox. Proceedings of the Society for Experimental Biology and Medicine. (1952). URL: https://www.semanticscholar.org/paper/ba12c87f9b8ef742b9307e8dc744a5044aee4005

[5] Perera, L., Mosca, J., Ruyechan, W., et al. Regulation of varicella-zoster virus gene expression in human T lymphocytes. Journal of Virology. (1992). URL: https://www.semanticscholar.org/paper/92af68d05bee382b636f736772c89cd28aa31c65

[6] Arvin, A. Varicella-zoster virus. Clinical Microbiology Reviews. (1996). URL: https://www.semanticscholar.org/paper/84a355ef8c0f8c8f11bbd4edec50b54f36fdaf06

[7] Norberg, P., Depledge, D., Kundu, S., et al. Recombination of Globally Circulating Varicella-Zoster Virus. Journal of Virology. (2015). URL: https://www.semanticscholar.org/paper/54b06ab984fff71906ea85072ab0758a17a0678e

[8] Kennedy, P. G. E., Montague, P. Variable Gene Expression in Human Ganglia Latently Infected with Varicella-Zoster Virus. Viruses. (2022). URL

[9] Grose, C., Edwards, D. P., Weigle, K. A., et al. Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology. (1984). URL: https://www.semanticscholar.org/paper/93f74959d730ba3ed4af6992c235679db2977e9f

[10] Xue, W., Li, T., Zhang, S., et al. Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice. Viruses. (2022). URL: https://www.semanticscholar.org/paper/97e939f1e741d8dbeac0ed96c3879119a06ef203

[11] Oliver, S., Zhou, M., Arvin, A. Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis. Biochemical Society Transactions. (2020). URL: https://www.semanticscholar.org/paper/91b4afc721e126110bc7d2b334a66cbdd35da7c

[12] Eberhardt, C., Wieland, A., Nasti, T., et al. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination. Journal of Virology. (2020). URL: https://www.semanticscholar.org/paper/0e423341174932cdb8c60687b3f71504ab242b0e

[13] Kennedy, P., Mogensen, T., Cohrs, R. Recent Issues in Varicella-Zoster Virus Latency. Viruses. (2021). URL: https://www.semanticscholar.org/paper/2364be73e596d0ce9857cc8bed60741937d217e0

[14] Baird, N. L., Zhu, S., Pearce, C. M., et al. Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation. Viruses. (2019). URL: https://www.semanticscholar.org/paper/9fc6d77a782a65487bebf72eaaf18b68b4982e06

[15] Wong, V., Levin, T. R. epidemiology of herpes zoster. Journal. (2019). URL: https://www.semanticscholar.org/paper/aa578e38f748a52166e174ba5a025e57a6de8dc2

[16] Kennedy, P. The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation. Viruses. (2023). URL: https://www.semanticscholar.org/paper/697b9f0b759a17c74b89537cb110d2ac1acde41c

[17] Gor, N. M., Mevawala, H. B., Tanna, S. S., et al. Varicella bullosa a rare form of chickenpox in an immunocompromised child: a case study. International Journal of Research in Medical Sciences. (2024). URL: https://www.semanticscholar.org/paper/471c4e86439de38fe45a94d064b691873bfc92c7

[18] Rossetto, C. L., Sepkowitz, K. A., Ackerman, J., et al. Management of a Major Varicella Zoster Exposure in a Pediatric Oncology Population. Pediatric Hematology & Oncology. (2024). URL: https://www.semanticscholar.org/paper/1447c8630d88e2d33efca9c9d7297802e9c9dfba

[19] Кольцова, Домонова, Сильвейстрова, et al. Chicken pox and pregnancy: risks to mother and fetus. Ways to solve the problem. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). (2021). URL: https://www.semanticscholar.org/paper/8dff39fe3ae587ec0a1044df91eeebfe4f01eff7

[20] Salmoniere, P., Janier, M., Gilquin, J., et al. Chicken pox and acute monocytic leukaemia skin lesions in an HIV-seropositive man. Clincal and Experimental Dermatology. (1994). URL: https://www.semanticscholar.org/paper/28ba3516a0231a49f8d957d3b58f9eb2141ab65a

[21] Duong, T., Poszepczynska-Guigné, E., Challine, D., et al. A new cause of 'gloves and socks' syndrome: chicken pox. Journal of the European Academy of Dermatology and Venereology. (2009). URL: https://www.semanticscholar.org/paper/4526abc328f454b14a1e5901a4d29d75e240d7fe

[22] Nagel, M., Gilden, D. Developments in Varicella Zoster Virus Vasculopathy. Current Neurology and Neuroscience Reports. (2016). URL: https://www.semanticscholar.org/paper/ce2c9f7ee0fa4c05ec3947d3424221c562020f41

[23] Kennedy, P. Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV). Neurotherapeutics. (2016). URL: https://www.semanticscholar.org/paper/67d9094e9cc8bd5a628af31b8334ad37ec338bea

[24] Taylor-Robinson, D., Downie, A. Chicken-pox and Herpes Zoster: I. Complement Fixation Studies. Journal. (1959). URL: https://www.semanticscholar.org/paper/14fbd36a04ed16f70fa461e75f6e98985a7273d2

[25] br tarigan, J., Putri, M., Br. Purba, S. U., et al. Human Monkeypox Virus infection. MEDISTRA MEDICAL JOURNAL (MMJ). (2025). URL: https://www.semanticscholar.org/paper/149dfcb3b1d45c2b8fdf58e5f685101569959436

[26] Garcés-Ayala, F., Rodríguez-Castillo, A., Ortíz-Alcántara, J., et al. Full-Genome Sequence of a Novel Varicella-Zoster Virus Clade Isolated in Mexico. Genome Announcements. (2015). URL: https://www.semanticscholar.org/paper/0a2c38bfe0ddc47fcc4b4564af5f3d58e1c0909b

[27] Havlik, R. J., Blackwelder, W. C., Kaslow, R. A., et al. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages. The Framingham Heart Study. Arteriosclerosis. (1989). URL: https://www.semanticscholar.org/paper/fcb36c171168f97d56c2516e02edb8460126cb8b

[28] Sen, N., Mukherjee, G., Bendall, S., et al. 233: Multiparametric high dimensional analysis of normal & VZV infected human tonsil T cells at a single cell resolution by mass cytometry. Journal. (2013). URL: https://www.semanticscholar.org/paper/32fcf80bf651cc6f9bb5a8751e8eff51316a4c74

[29] Norberg, P. Evolution of human alpha-herpesviruses. Journal. (2007). URL: https://www.semanticscholar.org/paper/b469a15d4ed7e67908c39e9e82d594a6ebd29305

[30] Moffat, J., Taylor, S. L., Leisenfelder, S. A. Viral and cellular kinases play a central role in VZV pathogenesis and are targets for antiviral kinase inhibitors. Journal. (2003). URL: https://www.semanticscholar.org/paper/15a47c18942b6487ec77a8b14724db23cf05014a

[31] Raza, M., Farwa, U., Ishaque, F., et al. Designing of thiazolidinones against chicken pox, monkey pox, and hepatitis viruses: A computational approach. Comput. Biol. Chem. (2023). URL: https://www.semanticscholar.org/paper/eb9c5821742c91bbb35f4b977a500c94793f4bf2

[32] Painton, G. R. THE DIAGNOSIS OF SMALL-POX AND CHICKEN-POX: A CONTRAST. British medical journal. (1923). URL: https://www.semanticscholar.org/paper/5dda78cebed1cd65571bc3abe944d87a07e573e8

[33] Elkada, L., Ouanounou, A. Management of Oral Manifestations of Herpes Simplex Virus, Varicella Zoster Virus, and Human Papillomavirus. Compendium of continuing education in dentistry. (2024). URL: https://www.semanticscholar.org/paper/fe6f3dfc0d8ec12527bde944f4de68de62338a45

[34] Munasinghe, B. M., Fernando, U., Mathurageethan, M., et al. Reactivation of varicella-zoster virus following mRNA COVID-19 vaccination in a patient with moderately differentiated adenocarcinoma of rectum: A case report. SAGE Open Medical Case Reports. (2022). URL: https://www.semanticscholar.org/paper/e24e8f6ec0c7e3b1bfd574be1e1316e6d791fb8f

[35] Lloyd, M., Liu, D., Lyu, J., et al. An acyclic phosphonate prodrug of HPMPC is effective against VZV in skin organ culture and mice. bioRxiv. (2022). URL: https://www.semanticscholar.org/paper/87cdae7d0105978ab1a618df3cf2eb5739e88e50